Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MNK

Mallinckrodt (MNK)

Mallinckrodt plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:MNK
DatumZeitQuelleÜberschriftSymbolFirma
29/08/202313h22IH Market NewsTuesday’s Wall Street Highlights: Alphabet, Verizon, Joann, Intel, Catalent, and moreAMEX:MNKMallinckrodt plc
28/08/202310h46PR Newswire (US)Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid ObligationsAMEX:MNKMallinckrodt plc
28/08/202306h17PR Newswire (US)Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid ObligationsAMEX:MNKMallinckrodt plc
23/08/202314h32PR Newswire (US)Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring PlanAMEX:MNKMallinckrodt plc
23/08/202314h22PR Newswire (US)Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring PlanAMEX:MNKMallinckrodt plc
09/08/202312h45PR Newswire (US)Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year GuidanceAMEX:MNKMallinckrodt plc
15/06/202312h52PR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) Congress 2023AMEX:MNKMallinckrodt plc
13/06/202308h30PR Newswire (US)Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant PatientsAMEX:MNKMallinckrodt plc
01/06/202312h52PR Newswire (US)Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023AMEX:MNKMallinckrodt plc
09/05/202312h45PR Newswire (US)Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year GuidanceAMEX:MNKMallinckrodt plc
08/05/202312h52PR Newswire (US)Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023AMEX:MNKMallinckrodt plc
05/05/202312h52PR Newswire (US)Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact AwardsAMEX:MNKMallinckrodt plc
28/04/202314h00Business WireBuxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Failure to Address Evidential Multibillion-Dollar Asset Value Depreciation Expense Concealment SchemeAMEX:MNKMallinckrodt plc
24/04/202312h45PR Newswire (US)Mallinckrodt to Report Earnings Results for First Quarter 2023AMEX:MNKMallinckrodt plc
10/04/202312h53PR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM)AMEX:MNKMallinckrodt plc
21/03/202311h53PR Newswire (US)Mallinckrodt to Present New Retrospective Data on Effect of Acthar® Gel (Repository Corticotropin Injection) to Reduce Corticosteroid Use and Burden for Advanced Sarcoidosis at the Academy of Managed Care Pharmacy (AMCP) 2023 Annual MeetingAMEX:MNKMallinckrodt plc
09/03/202309h00PR Newswire (US)Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)AMEX:MNKMallinckrodt plc
28/02/202312h45PR Newswire (US)Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 GuidanceAMEX:MNKMallinckrodt plc
16/02/202314h03PR Newswire (US)Mallinckrodt to Present at Cowen's 43rd Annual Health Care ConferenceAMEX:MNKMallinckrodt plc
08/02/202312h45PR Newswire (US)Mallinckrodt to Report Earnings Results for Fourth Quarter 2022AMEX:MNKMallinckrodt plc
22/01/202320h00PR Newswire (US)Mallinckrodt Presents New TERLIVAZ® (terlipressin) for Injection Data on Hepatorenal Syndrome (HRS) Reversal at the Society of Critical Care Medicine (SCCM) 2023 Critical Care CongressAMEX:MNKMallinckrodt plc
16/11/202212h52PR Newswire (US)Mallinckrodt Announces 2022 Advancing Extracorporeal Photopheresis Immunomodulation Investigator AwardAMEX:MNKMallinckrodt plc
08/11/202212h45PR Newswire (US)Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms GuidanceAMEX:MNKMallinckrodt plc
01/11/202211h53PR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2022 Scientific MeetingAMEX:MNKMallinckrodt plc
 Showing the most relevant articles for your search:AMEX:MNK